HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hereditary kidney cancers: The pathologist's view in 2020].

Abstract
Hereditary predispositions to adult kidney tumors involve around 5% of tumors and include a dozen of autosomal dominant syndromes. The most frequent tumors encountered in these setting are clear cell renal cell carcinomas, papillary renal cell carcinomas, chromophobe renal cell carcinomas and angiomyolipomas. Their detection is essential in order to adapt individual care and perform genetic screening of at-risk relatives, especially in the national french network PREDIR, labeled by the National Cancer Institute and dedicated to hereditary predispositions to kidney tumors. Targeted genetic analysis, which was guided in particular by the renal tumor subtype, has recently evolved into genetic analysis using panels of genes. Pathologist contribution's remains however central in the diagnosis of hereditary forms since we currently have immunohistochemical biomarkers that allow us to diagnose two specifically hereditary entities: hereditary leiomyomatosis and renal cell carcinoma associated-renal cell carcinoma, associated with a loss of fumarate hydratase and succinate dehydrogenase-deficient renal cell carcinoma associated with a loss of succinate deshydrogenase B expression. These diagnoses must however be confirmed by the identification of pathogenic germline variation in the corresponding genes. Improvement of kidney tumors characterization has also lead to identify new subtypes, expanding the algorithm of renal tumors associated with hereditary setting. Here we aim to review all subtypes of adult renal tumors encountered in predisposition syndromes.
AuthorsVirginie Verkarre, Aurélien Morini, Thomas Denize, Sophie Ferlicot, Stéphane Richard
JournalAnnales de pathologie (Ann Pathol) Vol. 40 Issue 2 Pg. 148-167 (Apr 2020) ISSN: 0242-6498 [Print] France
Vernacular TitleLes cancers du rein héréditaires vus par le pathologiste en 2020.
PMID32197858 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2020 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • Fumarate Hydratase
Topics
  • Angiomyolipoma (diagnosis, genetics, pathology)
  • Biomarkers, Tumor (genetics)
  • Carcinoma, Renal Cell (diagnosis, genetics, pathology)
  • Fumarate Hydratase (genetics)
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Germ-Line Mutation
  • Humans
  • Immunohistochemistry
  • Kidney Neoplasms (diagnosis, genetics, pathology)
  • Neoplastic Syndromes, Hereditary (diagnosis, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: